Vol 7, No 5 (October 01, 2016): Journal of Gastrointestinal Oncology (Genetic Diversity of Gastrointestinal Malignancies and Emerging Targets: A New World Order)

Editorial

Taking aim at the genomic diversity of gastrointestinal cancers: a changing landscape

Tanios Bekaii-Saab, Bassel El-Rayes

PDF Pages: 673-674 Full Text (2593) Open Access

Review Article

Clinical applications of liquid biopsies in gastrointestinal oncology

Jason Zhu, John H. Strickler

PDF Pages: 675-686 Full Text (7732) Open Access

RAS and BRAF in metastatic colorectal cancer management

Jun Gong, May Cho, Marwan Fakih

PDF Pages: 687-704 Full Text (20795) Open Access

Beyond RAS and BRAF: a target rich disease that is ripe for picking

Tyler Friedrich, Stephen Leong, Christopher H. Lieu

PDF Pages: 705-712 Full Text (6104) Open Access

Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others

Manojkumar Bupathi, Christina Wu

PDF Pages: 713-720 Full Text (9577) Open Access

Summary of emerging targets in anal cancer: the case for an immunotherapy based-approach

Van Morris, Cathy Eng

PDF Pages: 721-726 Full Text (4813) Open Access

Personalized medicine in sporadic pancreatic cancer without homologous recombination-deficiency: are we any closer?

Namrata Vijayvergia, Steven J. Cohen

PDF Pages: 727-737 Full Text (5935) Open Access

Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?

Min Yuen Teo, Eileen M. O’Reilly

PDF Pages: 738-749 Full Text (6808) Open Access

The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyond

Ciara M. Kelly, Yelena Y. Janjigian

PDF Pages: 750-762 Full Text (14334) Open Access

Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers

Jimmy Hwang

PDF Pages: 763-770 Full Text (4347) Open Access

The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1

Zhaohui Jin, Harry H. Yoon

PDF Pages: 771-788 Full Text (13297) Open Access

The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?

Sumera I Ilyas, Mitesh J. Borad

PDF Pages: 789-796 Full Text (6792) Open Access

Molecular profiling of biliary tract cancer: a target rich disease

Apurva Jain, Milind Javle

PDF Pages: 797-803 Full Text (12031) Open Access

Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?

Michael S. Lee, Bert H. O’Neil

PDF Pages: 804-818 Full Text (6004) Open Access

Disclosure:

The focused issue “Genetic Diversity of Gastrointestinal Malignancies and Emerging Targets: A New World Order” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Tanios Bekaii-Saab and Bassel El-Rayes served as the unpaid Guest Editors for the focused issue.